February 2021 – Canadian Nuclear Isotope Council

CPDC Announces First Patient Dosed in a Phase 3 Clinical Trial of a Prostate Cancer Diagnostic Imaging Product, [18F]PSMA-1007

February 25, 2021

Hamilton, Ontario, February 24, 2021 – The Centre for Probe Development and Commercialization (CPDC), a global leader in the development, production and commercialization of radiopharmaceuticals, is announcing today that the first patient has been dosed and imaged in a Phase 3 trial for [18F]PSMA-1007. This diagnostic imaging product is a positron-emitting tomography (PET) agent that … Read more

Pacer Air freight and CNIC Partner to address isotope supply chain challenges

February 9, 2021

Ensuring a reliable supply of medical isotopes for patients at the heart of new partnership TORONTO – February 9, 2021 – Pacer Air Freight, an independent freight forwarder and leader in delivering life-saving supplies to hospitals and research institutions worldwide, has joined the Canadian Nuclear Isotope Council (CNIC). The world has always counted on Canada … Read more